120 related articles for article (PubMed ID: 6485956)
1. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
Nishio S; Ozaki Y; Wada S; Kawakita J; Maekawa M
Hinyokika Kiyo; 1984 Apr; 30(4):449-57. PubMed ID: 6485956
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of serum immunosuppressive acidic protein (IAP) and acid soluble glycoproteins (ASP) in patients with malignant tumors].
Shibasaki K; Soga K; Toshima M; Aikawa K; Tsuruya T; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K
Shigaku; 1989 Aug; 77(2):701-11. PubMed ID: 2489324
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of serum acid soluble glycoproteins (ASP) and immunosuppressive acidic protein (IAP) in inflammatory diseases and liver diseases].
Shibasaki K; Soga K; Toshima M; Aikawa K; Itoh T; Takahashi Y; Tsuchimochi M; Mataga I; Tsuchikawa K; Kato J
Shigaku; 1989 Oct; 77(3):1031-41. PubMed ID: 2489330
[TBL] [Abstract][Full Text] [Related]
4. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. I. PHA-induced lymphocyte transformation.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):336-41. PubMed ID: 429127
[TBL] [Abstract][Full Text] [Related]
5. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance].
Ogoshi K; Kondoh Y; Nakasaki H; Tajima T; Mitomi T
Gan No Rinsho; 1983 Aug; 29(9):987-90. PubMed ID: 6688640
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between serum immunosuppressive acidic protein (IAP) and cellular immunity in the patients with gastric cancer].
Nakanishi K; Toge T; Hamamoto S; Tanada M; Itagaki E; Kohno H; Yanagawa E; Hattori T
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1827-31. PubMed ID: 6223588
[TBL] [Abstract][Full Text] [Related]
10. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
Kikuchi S
Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
[TBL] [Abstract][Full Text] [Related]
11. Serum immunosuppressive acidic protein levels in patients with severe acute pancreatitis.
Shinzeki M; Ueda T; Takeyama Y; Yasuda T; Sawa H; Nakajima T; Matsumoto I; Fujita T; Ajiki T; Fujino Y; Kuroda Y
Pancreas; 2007 Nov; 35(4):327-33. PubMed ID: 18090238
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
Takada M
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Sakita M; Yamane T; Kasuga M; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1755-64. PubMed ID: 7184372
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of serum immunosuppresive acidic protein levels in gynecological tumor].
Zhang W; Wang P; Zhao Y
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):194-6. PubMed ID: 11601039
[TBL] [Abstract][Full Text] [Related]
15. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
[TBL] [Abstract][Full Text] [Related]
16. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
17. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
Sato T; Sakata Y; Tamura K
Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of tissue polypeptide antigen in patients with esophageal, stomach and colon cancer].
Ogoshi K; Kondo Y; Akiba Y; Sugihara T; Ko S; Noto T; Makuuchi H; Tajima T; Mitomi T
Gan No Rinsho; 1984 Aug; 30(10):1299-302. PubMed ID: 6481966
[TBL] [Abstract][Full Text] [Related]
19. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
Kageyama T; Oyabu H; Ohshiba S
Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]